Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04178551 · ClinicalTrials.gov registry record · NA
Consortium to Disseminate and Understand Implementation of Opioid Use Disorder Treatment
A NA study of Opioid Medication Assisted Treatment, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 11
- Study locations
NCT04178551 is a NA study of Opioid Medication Assisted Treatment that has completed, run by VA Office of Research and Development. The registered enrollment target is 63 participants. The trial reports 11 study locations across 11 states.
The verdict
NCT04178551, a NA study of Opioid Medication Assisted Treatment, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 11
- Study locations
Study Summary
Opioid use disorder (OUD) is a major cause of illness and death among Veterans for which effective treatment is a major priority of the Veterans Health Administration (VHA). Expanding access to alternatives to opioid medications for chronic pain management is also a leading priority. Effective medications for OUD (MOUD) are available, but their availability and use among Veterans varies across VHA. The aims of this study are to pull together the efforts of six individual pilot projects into a single project. The purpose of combining the projects is to maximize the value of the individual projects to VHA and to provide information to guide strategies to increase access and use of MOUD and alternative therapies for pain in VHA nationally. The researchers leading the individual projects will make use of their partnerships with Veterans Integrated Service Network (VISN) leaders in order to develop a combined effort toward increased dissemination and use of MOUD that spans 9 VISNs and 63 sites.
Conditions Studied
Interventions
- OTHER Implementation Facilitation
Study Locations (11)
Alabama
- Birmingham VA Medical Center, Birmingham, AL - Birmingham
California
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles
Colorado
- Rocky Mountain Regional VA Medical Center, Aurora, CO - Aurora
Connecticut
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven
Idaho
- Boise VA Medical Center, Boise, ID - Boise
Iowa
- Iowa City VA Health Care System, Iowa City, IA - Iowa City
Maine
- Maine VA Medical Center, Augusta, ME - Augusta
Massachusetts
- VA Central Western Massachusetts Healthcare System, Leeds, MA - Leeds
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04178551
The ClinicalTrials.gov registry entry for NCT04178551 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Medication Assisted Treatment appearing as the primary indexed condition, and to 1 intervention - of which Implementation Facilitation is the first listed.
NCT04178551 reports 11 study locations spanning 11 distinct geographic areas - top geographies include Alabama, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT04178551 about?
NCT04178551 is a clinical study titled "Consortium to Disseminate and Understand Implementation of Opioid Use Disorder Treatment". Opioid use disorder (OUD) is a major cause of illness and death among Veterans for which effective treatment is a major priority of the Veterans Health Administration (VHA). Expanding access to alternatives to opioid medications for chronic pain management is also a leading priority. Effective medic...
What is the current status of trial NCT04178551?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2019-10-01. Estimated completion is 2022-09-30.
What conditions does trial NCT04178551 study?
This clinical trial studies the following conditions: Opioid Medication Assisted Treatment.
What interventions are being tested in trial NCT04178551?
The interventions under investigation include: Implementation Facilitation (OTHER).
Who is sponsoring clinical trial NCT04178551?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04178551 being conducted?
This trial has 11 study locations across Alabama, California, Colorado, Connecticut, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Medication Assisted Treatment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.